BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 22201103)

  • 1. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
    Hokugo A
    Clin Calcium; 2012 Jan; 22(1):83-90. PubMed ID: 22201103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic suppression of osteoclasts may play a role in developing bisphosphonate-related osteonecrosis of the jaw.
    Yin G; Bai Y; Luo E
    Med Hypotheses; 2011 Mar; 76(3):347-9. PubMed ID: 21074946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
    Allen MR; Burr DB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bisphosphonates and osteonecrosis of the jaw].
    Saussez S; Filleul O; Loeb I
    Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
    Yoneda T
    Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.
    Schaudinn C; Gorur A; Webster P; Jones AC; Neely M; Jelliffe RW; Le AD; Sedghizadeh PP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):480-6. PubMed ID: 22986243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus and bisphosphonate-related osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2009 Sep; 19(9):1332-8. PubMed ID: 19721206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
    Eid A; Atlas J
    Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):231-7. PubMed ID: 24794267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate-related osteonecrosis of the jaws.
    Ruggiero SL
    Compend Contin Educ Dent; 2008 Mar; 29(2):96-8, 100-2, 104-5. PubMed ID: 18429424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-related osteonecrosis of the jaw: what we have learned.
    Tabari E; Sikavi C
    Alpha Omegan; 2014; 107(2):8-15. PubMed ID: 25269218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study.
    Dayisoylu EH; Şenel FÇ; Üngör C; Tosun E; Çankaya M; Ersöz S; Taskesen F
    Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1475-80. PubMed ID: 23746422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws.
    Freiberger JJ
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):96-106. PubMed ID: 19371820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?
    Pichardo SE; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):287-92. PubMed ID: 23953415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of bisphosphonate-associated osteonecrosis of the jaws and its management.
    Lam DK; Sándor GK; Holmes HI; Evans AW; Clokie CM
    J Can Dent Assoc; 2007 Jun; 73(5):417-22. PubMed ID: 17555652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S; Shenoy VK; Eachampati P; Uppal N
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary--Is the bone turnover of the jawbone and its possible over suppression by bisphosphonates of etiological importance for the pathogenesis of the bisphosphonate-related osteonecrosis?
    Carlson ER; Gerard DA
    J Oral Maxillofac Surg; 2014 May; 72(5):911-3. PubMed ID: 24480759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.